JumpSTART triage

Lexus Announces Extension to Safety Connect and Service Connect Trial Periods

Retrieved on: 
Wednesday, September 28, 2022
Safety, Safety Connect, Home Heating Emergency Assistance Through Transportation Act of 2014, JumpSTART triage, Toyota Motor North America, IPhone, Locator, Connect, Maintenance, Smart key, Technology, Harman Connected Services, G, SOS, Advanced Automatic Collision Notification, GPS, Mobile phone, Cassette tape, Satellite navigation device, Lexus, Android

Safety Connect and Service Connect, a suite of available services that help drivers stay secure while on the road, are now available with up to a 10-year trial* on select Lexus models.

Key Points: 
  • Safety Connect and Service Connect, a suite of available services that help drivers stay secure while on the road, are now available with up to a 10-year trial* on select Lexus models.
  • The suite of available Safety Connect services includes 24-hour emergency assistance, 24-hour enhanced roadside assistance, automatic collision notification and stolen vehicle locator**.
  • Service Connect offers vehicle health reports and detailed maintenance reminders with the ability to link a preferred Lexus dealer with select Lexus vehicles.
  • *The Safety Connect and Service Connect suite of services will be available with up to a 10-year trial (4G network dependent) for customers of select 2023 Lexus vehicles equipped with Lexus Interface.

Sight Sciences Receives FDA 510(k) Clearance of the TearCare® System for Treatment of Meibomian Gland Dysfunction (MGD), the Leading Cause of Dry Eye Disease

Retrieved on: 
Wednesday, December 22, 2021
U.S. Securities and Exchange Commission, Regulation, Duane syndrome, Nasdaq, Inflammation, Eyelid, Patient, Pain, Private Securities Litigation Reform Act, Time, Eye, Temperature, CEO, Exocrine gland, Securities Act of 1933, JumpSTART triage, Industry, Growth, Adult, Forward-looking statement, Food and Drug Administration, Intellectual property, COVID-19, Research, Securities Exchange Act of 1934, MD, Company, Entrepreneurship, Safety, DED, Food, Insurance, Clinical trial, MGD, GLOBE, Jumpstart Our Business Startups Act, FDA, Medical device, Cosmetics, Pharmaceutical industry, OSDI

Present in the vast majority of DED cases, MGD is largely undertreated, with no insured treatment options currently available that can address MGD as the root cause of dry eye.

Key Points: 
  • Present in the vast majority of DED cases, MGD is largely undertreated, with no insured treatment options currently available that can address MGD as the root cause of dry eye.
  • The eye care community is increasingly acknowledging the importance of treating underlying meibomian gland obstruction when present for optimal treatment of DED associated with MGD.
  • The TearCare System provides safe and effective localized heat therapy, in conjunction with manual gland expression, intended to help soften or liquify thickened meibum for effective gland clearance.
  • The TearCare System is indicated for the application of localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction, when used in conjunction with manual expression of the meibomian glands.